Not meaning to stir the pot either, but this just popped up here on NeuroTalk in Health News Headlines.

"Patients with multiple sclerosis who are taking the drug Tysabri are not being properly monitored for serious side effects because of health service budgetary cutbacks, a leading neurologist has warned..."

http://www.topix.net/med/neurology/2...ed-says-expert